Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

Clifford R Jr. Jack, Ronald Carl Petersen, Yue Cheng Xu, Stephen C. Waring, Peter C. O'Brien, Eric George Tangalos, Glenn E. Smith, Robert J. Ivnik, Emre Kokmen

Research output: Contribution to journalArticle

808 Citations (Scopus)

Abstract

Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal lobe (MTL) structures can discriminate between normal elderly control subjects and patients with Alzheimer's disease (AD) of moderate to advanced severity. In terms of clinical utility, however, a more important issue concerns the ability of the technique to differentiate between normal elderly control subjects and AD patients with the very mildest form of the disease. We performed MRI-based volumetric measurements of the hippocampus, parahippocampal gyrus, and amygdala in 126 cognitively normal elderly control subjects and 94 patients with probable AD. The diagnosis of AD was made according to NINDS/ADRDA criteria, and disease severity was categorized by Clinical Dementia Rating (CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR 1 as mild, and CDR 2 as moderate disease severity. Volumes of each structure declined with increasing age in control subjects and did so in parallel for men and women. The volume of each measured MTL structure also declined with age in patients with AD. The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001). Of the several MTL measures, the total hippocampal volumetric measurements were best at discriminating control subjects from AD patients. The mean hippocampal volumes for AD patients relative to control subjects by severity of disease were as follows: very mild AD (CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, and moderate AD (CDR 2) -2.22 SD. Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.

Original languageEnglish (US)
Pages (from-to)786-794
Number of pages9
JournalNeurology
Volume49
Issue number3
StatePublished - Sep 1997

Fingerprint

Atrophy
Alzheimer Disease
Magnetic Resonance Imaging
Dementia
Temporal Lobe
National Institute of Neurological Disorders and Stroke
Parahippocampal Gyrus
Aptitude
Amygdala
Hippocampus

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. / Jack, Clifford R Jr.; Petersen, Ronald Carl; Xu, Yue Cheng; Waring, Stephen C.; O'Brien, Peter C.; Tangalos, Eric George; Smith, Glenn E.; Ivnik, Robert J.; Kokmen, Emre.

In: Neurology, Vol. 49, No. 3, 09.1997, p. 786-794.

Research output: Contribution to journalArticle

Jack, CRJ, Petersen, RC, Xu, YC, Waring, SC, O'Brien, PC, Tangalos, EG, Smith, GE, Ivnik, RJ & Kokmen, E 1997, 'Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease', Neurology, vol. 49, no. 3, pp. 786-794.
Jack, Clifford R Jr. ; Petersen, Ronald Carl ; Xu, Yue Cheng ; Waring, Stephen C. ; O'Brien, Peter C. ; Tangalos, Eric George ; Smith, Glenn E. ; Ivnik, Robert J. ; Kokmen, Emre. / Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. In: Neurology. 1997 ; Vol. 49, No. 3. pp. 786-794.
@article{094f1089e758425aade06c7b1c5483af,
title = "Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease",
abstract = "Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal lobe (MTL) structures can discriminate between normal elderly control subjects and patients with Alzheimer's disease (AD) of moderate to advanced severity. In terms of clinical utility, however, a more important issue concerns the ability of the technique to differentiate between normal elderly control subjects and AD patients with the very mildest form of the disease. We performed MRI-based volumetric measurements of the hippocampus, parahippocampal gyrus, and amygdala in 126 cognitively normal elderly control subjects and 94 patients with probable AD. The diagnosis of AD was made according to NINDS/ADRDA criteria, and disease severity was categorized by Clinical Dementia Rating (CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR 1 as mild, and CDR 2 as moderate disease severity. Volumes of each structure declined with increasing age in control subjects and did so in parallel for men and women. The volume of each measured MTL structure also declined with age in patients with AD. The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001). Of the several MTL measures, the total hippocampal volumetric measurements were best at discriminating control subjects from AD patients. The mean hippocampal volumes for AD patients relative to control subjects by severity of disease were as follows: very mild AD (CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, and moderate AD (CDR 2) -2.22 SD. Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.",
author = "Jack, {Clifford R Jr.} and Petersen, {Ronald Carl} and Xu, {Yue Cheng} and Waring, {Stephen C.} and O'Brien, {Peter C.} and Tangalos, {Eric George} and Smith, {Glenn E.} and Ivnik, {Robert J.} and Emre Kokmen",
year = "1997",
month = "9",
language = "English (US)",
volume = "49",
pages = "786--794",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

AU - Jack, Clifford R Jr.

AU - Petersen, Ronald Carl

AU - Xu, Yue Cheng

AU - Waring, Stephen C.

AU - O'Brien, Peter C.

AU - Tangalos, Eric George

AU - Smith, Glenn E.

AU - Ivnik, Robert J.

AU - Kokmen, Emre

PY - 1997/9

Y1 - 1997/9

N2 - Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal lobe (MTL) structures can discriminate between normal elderly control subjects and patients with Alzheimer's disease (AD) of moderate to advanced severity. In terms of clinical utility, however, a more important issue concerns the ability of the technique to differentiate between normal elderly control subjects and AD patients with the very mildest form of the disease. We performed MRI-based volumetric measurements of the hippocampus, parahippocampal gyrus, and amygdala in 126 cognitively normal elderly control subjects and 94 patients with probable AD. The diagnosis of AD was made according to NINDS/ADRDA criteria, and disease severity was categorized by Clinical Dementia Rating (CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR 1 as mild, and CDR 2 as moderate disease severity. Volumes of each structure declined with increasing age in control subjects and did so in parallel for men and women. The volume of each measured MTL structure also declined with age in patients with AD. The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001). Of the several MTL measures, the total hippocampal volumetric measurements were best at discriminating control subjects from AD patients. The mean hippocampal volumes for AD patients relative to control subjects by severity of disease were as follows: very mild AD (CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, and moderate AD (CDR 2) -2.22 SD. Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.

AB - Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal lobe (MTL) structures can discriminate between normal elderly control subjects and patients with Alzheimer's disease (AD) of moderate to advanced severity. In terms of clinical utility, however, a more important issue concerns the ability of the technique to differentiate between normal elderly control subjects and AD patients with the very mildest form of the disease. We performed MRI-based volumetric measurements of the hippocampus, parahippocampal gyrus, and amygdala in 126 cognitively normal elderly control subjects and 94 patients with probable AD. The diagnosis of AD was made according to NINDS/ADRDA criteria, and disease severity was categorized by Clinical Dementia Rating (CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR 1 as mild, and CDR 2 as moderate disease severity. Volumes of each structure declined with increasing age in control subjects and did so in parallel for men and women. The volume of each measured MTL structure also declined with age in patients with AD. The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001). Of the several MTL measures, the total hippocampal volumetric measurements were best at discriminating control subjects from AD patients. The mean hippocampal volumes for AD patients relative to control subjects by severity of disease were as follows: very mild AD (CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, and moderate AD (CDR 2) -2.22 SD. Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.

UR - http://www.scopus.com/inward/record.url?scp=0343416812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343416812&partnerID=8YFLogxK

M3 - Article

C2 - 9305341

AN - SCOPUS:0343416812

VL - 49

SP - 786

EP - 794

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -